DGAP-News: Kadimastem Awarded Patent in Japan for AstroRx速 For ALS and Drug Screening
businessinsider.com
finance
2022-05-30 15:10:18

DGAP-News: Kadimastem Kadimastem Awarded Patent in Japan for AstroRx速 For ALS and Drug Screening 30.05.2022 / 15:10 The issuer is solely responsible for the content of this announcement.Kadimastem Ltd. (TASE: KDST), a clinical stage cell therapy company developing a treatment for ALS, exploring one for multiple sclerosis and developing a potential cure for diabetes, has received a patent from the Japan Patent Office for AstroRx速 for the treatment of ALS and drug screening. The patent also protects AstroRx速 for the treatment of multiple sclerosis.
